C4 Therapeutics Inc. (CCCC) volume exceeds 0.65 million: A new investment opportunity for investors

January 24, 2023, C4 Therapeutics Inc. (NASDAQ: CCCC) trading session started at the price of $8.18, that was -1.82% drop from the session before. During the day, the shares moved up to $8.41 and dropped to $8.03 before settling in for the closing price of $8.24. A 52-week range for CCCC has been $4.84 – $26.80.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored


When this article was written, the company’s average yearly earnings per share was at -18.30%. With a float of $43.45 million, this company’s outstanding shares have now reached $48.92 million.

The firm has a total of 121 workers. Let’s measure their productivity. In terms of profitability, gross margin is +93.65, operating margin of -179.39, and the pretax margin is -183.23.

C4 Therapeutics Inc. (CCCC) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward C4 Therapeutics Inc. stocks. The insider ownership of C4 Therapeutics Inc. is 0.20%, while institutional ownership is 82.30%. The most recent insider transaction that took place on Apr 12, was worth 84,000. In this transaction President & CEO of this company bought 10,000 shares at a rate of $8.40, taking the stock ownership to the 10,000 shares.

C4 Therapeutics Inc. (CCCC) Recent Fiscal highlights

Going through the last 3-months fiscal report unveiled on the 6/29/2022, it has been observed that the corporation posted -$0.56 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.69) by $0.13. This company achieved a net margin of -183.23 while generating a return on equity of -25.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -18.30% per share during the next fiscal year.

C4 Therapeutics Inc. (NASDAQ: CCCC) Trading Performance Indicators

You can see what C4 Therapeutics Inc. (CCCC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.61.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.94 in one year’s time.

Technical Analysis of C4 Therapeutics Inc. (CCCC)

Analysing the last 5-days average volume posted by the [C4 Therapeutics Inc., CCCC], we can find that recorded value of 0.4 million was lower than the volume posted last year of 0.43 million. As of the previous 9 days, the stock’s Stochastic %D was 49.97%. Additionally, its Average True Range was 0.69.

During the past 100 days, C4 Therapeutics Inc.’s (CCCC) raw stochastic average was set at 37.83%, which indicates a significant decrease from 58.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.53% in the past 14 days, which was lower than the 90.35% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $7.83, while its 200-day Moving Average is $8.76. Now, the first resistance to watch is $8.32. This is followed by the second major resistance level at $8.56. The third major resistance level sits at $8.70. If the price goes on to break the first support level at $7.94, it is likely to go to the next support level at $7.80. Now, if the price goes above the second support level, the third support stands at $7.56.

C4 Therapeutics Inc. (NASDAQ: CCCC) Key Stats

There are 48,957K outstanding shares of the company, which has a market capitalization of 367.45 million. As of now, sales total 45,790 K while income totals -83,890 K. Its latest quarter income was 6,750 K while its last quarter net income were -31,960 K.

Latest

On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...

Newsletter

 

Don't miss

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

5 Best TaaS Stocks to Buy Right Now

TaaS stock refers to a financial asset sold by...

The Charles Schwab Corporation (SCHW) return on Assets touches 1.18: These Shares are Poised for Major Movement

The Charles Schwab Corporation (NYSE: SCHW) open the trading on January 26, 2023, with a bit cautious approach as it glided -1.46% to $78.05....

Plug Power Inc. (PLUG) is predicted to post EPS of -0.22 in the upcoming quarter : This Stock is Ticking Every Box for Top...

Witnessing the stock’s movement on the chart, on January 26, 2023, Plug Power Inc. (NASDAQ: PLUG) had a quiet start as it plunged -5.94%...

BlackLine Inc. (BL) EPS growth this year is -139.10%: Get Prepared for Trading Lift Off

BlackLine Inc. (NASDAQ: BL) established initial surge of 3.78% at $69.74, as the Stock market unbolted on January 26, 2023. During the day, the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here